The purpose of this study is to evaluate the safety and tolerability of short-term dosing of
IV doxycycline when administered concomitantly with IV Valortim in normal healthy human
subjects.
Phase:
Phase 1
Details
Lead Sponsor:
PharmAthene, Inc.
Collaborators:
Department of Health and Human Services Medarex National Institutes of Health (NIH) Quintiles, Inc.